Technical Note: Dosimetric characteristics of the ocular beam line and commissioning data for an ocular proton therapy planning system at the Proton Therapy Center Houston

Purpose: To systematically analyze and present the properties of a small‐field, double‐scattering proton beam line intended to be used for the treatment of ocular cancer, and to provide configuration data for commission of the Eclipse Ocular Proton Planning System. Methods: Measurements were made using ionization chambers, diodes, and films to determine dose profiles and output factors of the proton beams of the beam line at the Proton Therapy Center Houston. In parallel, Monte Carlo simulations were performed to validate the measured data and to provide additional insight into detailed beam parameters that are hard to measure, such as field size factors and a comparison of output factors as a function of circular and rectangular fields. Results: The presented data comprise depth dose profiles, including distal and proximal profiles used to configure the Eclipse Ocular Proton Planning system, distal fall‐off widths, lateral profiles and penumbrae sizes, as well as output factors as a function of field size, SOBP width, range shifter thickness, snout position, and source‐to‐surface distance. Conclusions: We have completed a comprehensive characterization of the beam line. The data will be useful to characterize proton beams in clinical and experimental small‐field applications.

[1]  A. Wroe,et al.  Evaluation of the dosimetric properties of a diode detector for small field proton radiosurgery. , 2015, Journal of applied clinical medical physics.

[2]  D. Yeung,et al.  Dosimetric properties of a proton beamline dedicated to the treatment of ocular disease. , 2013, Medical physics.

[3]  Harald Paganetti,et al.  Proton therapy physics , 2011 .

[4]  P. Olko,et al.  Proton radiotherapy facility for ocular tumors at the IFJ PAN in Kraków Poland. , 2010, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[5]  Harald Paganetti,et al.  Field size dependence of the output factor in passively scattered proton therapy: influence of range, modulation, air gap, and machine settings. , 2009, Medical physics.

[6]  Bijan Arjomandy,et al.  A procedure for calculation of monitor units for passively scattered proton radiotherapy beams. , 2008, Medical physics.

[7]  George Starkschall,et al.  Determination of output factors for small proton therapy fields. , 2007, Medical physics.

[8]  Harald Paganetti,et al.  The prediction of output factors for spread-out proton Bragg peak fields in clinical practice , 2005, Physics in medicine and biology.

[9]  大谷 浩樹.  Charged Particle Equilibrium of Small Field in Clinical Proton Beams , 2005 .

[10]  W. Newhauser,et al.  Virtual commissioning of a treatment planning system for proton therapy of ocular cancers. , 2005, Radiation protection dosimetry.

[11]  Uwe Titt,et al.  Monte Carlo simulations of a nozzle for the treatment of ocular tumours with high-energy proton beams , 2005, Physics in medicine and biology.

[12]  P Chauvel,et al.  Monte Carlo simulation of a protontherapy platform devoted to ocular melanoma. , 2005, Medical physics.

[13]  W. Newhauser,et al.  Dosimetry for ocular proton beam therapy at the Harvard Cyclotron Laboratory based on the ICRU Report 59. , 2002, Medical physics.

[14]  M Silari,et al.  Physical specifications of clinical proton beams from a synchrotron. , 1996, Medical physics.

[15]  R Goodall,et al.  The 62 MeV proton beam for the treatment of ocular melanoma at Clatterbridge. , 1993, The British journal of radiology.

[16]  P. V. Vavilov.  IONIZATION LOSSES OF HIGH-ENERGY HEAVY PARTICLES , 1957 .